Ondansetron Tablet

Leading of zofer md 4 tablet, 4mg fabdissolve ondansetron tablets ip and 4mg amotic md ondansetron orally disintegrating tablets ip from Greater Noida.

Zofer Md 4 Tablet

Request Callback

₹ 185 Get Latest Price

Product Brochure
Dose/Strength4mg
Strength4 mg
Packaging Size1X10 Tablets
Packaging TypeBox
BrandZofer
Also givesThird Party Manufacturing
Prescription/Non prescriptionPrescription
Shelf Life24 Month
FormTablets
CompositionOndansetron Orally Disintegrating
Zofer Md 4 Tablet is an Antiemetic Medicine Commonly Used to Control Nausea and Vomiting Due to Certain Medical Conditions Like Stomach Upset. It is Also Used to Prevent Nausea and Vomiting Caused Due to Any Surgery, Cancer Drug Therapy, or Radiotherapy.

4mg Fabdissolve Ondansetron Tablets IP

Request Callback

₹ 512 Get Latest Price

Strength4 mg
Packaging Size10X10 Tablets
Packaging TypeBox
BrandFabdissolve
Manufactured ByFabcon Lifesciences Pvt Ltd
TreatmentUsed to Prevent Nausea and Vomiting
CompositionOndansetron
Ondansetron is Used to Prevent Nausea and Vomiting Caused by Cancer Chemotherapy, Radiation Therapy, and Surgery. Ondansetron is in a Class of Medications Called Serotonin 5-ht3 Receptor Antagonists. It Works by Blocking the Action of Serotonin, a Natural Substance That May Cause Nausea and Vomiting.

4mg Amotic MD Ondansetron Orally Disintegrating Tablets IP

Request Callback

₹ 245 Get Latest Price

Dose/Strength4 mg
Packaging Size20X10 Tablets
Packaging TypeBox
BrandAmotic MD
Manufactured BySignature
CompositionOndansetron
TreatmentUsed to Control Nausea and Vomiting Due to Certain Medical Conditions
FormTablet
Amotic MD 4mg Tablet is an Antiemetic Medicine Commonly Used to Control Nausea and Vomiting Due to Certain Medical Conditions Like Stomach Upset. It is Also Used to Prevent Nausea and Vomiting Caused Due to Any Surgery, Cancer Drug Therapy, or Radiotherapy.
X

Contact Us

Akash Bansal (CEO)
Healtech Pharma
Shop No. 32, K.B Complex, Alpha 2
Greater Noida - 201310, Gautam Buddha Nagar, Uttar Pradesh, India

Send Email
Share: